Delivery Order SPE2DB20D7066-SPE2DB25FC4VY
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ultane 250 ML pen bottles with a ceiling value of $1,347.64. This firm fixed price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Ultane 250 ml pen bottles. The contract has a ceiling value of $1,251.38 and is classified as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025. The place of performance is located in Conshohocken, Pennsylvania, which is also the company's corporate headquarters. This award was not set aside for small businesses or...
- The Defense Logistics Agency awarded a $1,202.68 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ultane 250 ml pen bottles. This firm fixed price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottle pharmaceutical product with a ceiling value of $1,443.90. Issued on August 5, 2025, this firm fixed price contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this award, reflecting the...
- This delivery order, awarded September 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Ultane 250 ML pen bottles at a firm fixed price of $2,355.61, with completion scheduled for September 19, 2025. The contract is not set-aside and was competitively awarded to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ultane 250 ML pen bottles. This firm fixed-price delivery order, valued at $1,299.51, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), an agreement valued at $999.999 billion through December 2026. The contract involves no set-aside designation and was competitively awarded through...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ultane Liquid 250ML, with a firm fixed price ceiling value of $2,816.90 and completion targeted for August 19, 2025. This competitively awarded, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with the Defense Logistics Agency Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp for the supply of Ultane 250 ML in pen bottle format on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract action performed at the contractor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen Drug Corp's substantial...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,780.81 by the Defense Logistics Agency (DLA) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract, designated as a child order under a larger indefinite delivery contract (IDC), covers the supply of Ultane 250 mL pen bottle medication. This delivery order was competitively awarded with firm fixed-price pricing...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4VYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,176.58 to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottles on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract with DLA. The product will be delivered to the company's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and operates as a major pharmaceutical distributor for federal medical procurement. This delivery order falls under AmerisourceBergen's substantial $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The company's federal contract portfolio demonstrates extensive capability in supplying a broad range of pharmaceutical products and medical supplies to support Department of Defense and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The indefinite delivery contract framework enables flexible procurement of critical medical commodities across multiple therapeutic domains to support worldwide military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/18/25 |